---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-24-000105"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:16:48.146992+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Senti subleases 7,247 RSF of HQ to BKPBIOTECH/JLSA2 Therapeutics

## Summary
- Sublease of 7,247 rentable sq ft on first floor at Two Corporate Drive, South San Francisco.
- Term effective October 1, 2024 through April 30, 2027, subject to landlord consent.
- Initial monthly base rent $35,147.95, escalating to $36,378.13 (Y2) and $37,651.36 (Y3).
- Subtenant is jointly and severally BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc.

## SEC filing metadata
- accession: 0001854270-24-000105
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000105/0001854270-24-000105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000105/snti-20240923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-24-000105
- JSON: https://secwatch.observer/filing/0001854270-24-000105.json
- Plain text: https://secwatch.observer/filing/0001854270-24-000105.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.